While outsourcing does come with risks around loss of control and knowledge transfer, many companies have found that the benefits to both timelines and budgets make it worth pursuing. If done right, outsourcing drug development consulting may well be the competitive advantage biopharma companies need to bring innovative new therapies to patients faster.